Shares of GlaxoSmithKline Pharmaceuticals closed at Rs2,439.25 per scrip on BSE, down 0.41% from its previous close. Photo: Hemant Mishra/MintNew Delhi: Drug firm GlaxoSmithKline Pharmaceuticals on Friday reported a 69.38% rise in its standalone net profit to Rs89.69 crore for the quarter ended December 2017. The company had posted a net profit of Rs52.95 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing. “Overall underlying performance, excluding the impacts of GST and prior year disposals, is supported by high single to double-digit volume growth on our key brands and therapy areas,” GlaxoSmithKline Pharmaceuticals managing director A. Vaidheesh said. Shares of GlaxoSmithKline Pharmaceuticals closed at Rs2,439.25 per scrip on BSE, down 0.41% from its previous close.

Source: Mint February 02, 2018 14:03 UTC